Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation-Reference-Cited by-同舟云学术

Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation

Published:2018-02-09 Issue:6 Volume:53 Page:673-682
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Duinhouwer Lucia E.,Beije Nick^ORCID,van der Holt Bronno,Rijken-Schelen Anita,Lamers Cor H.^ORCID,Somers Judith,Braakman Eric,Cornelissen Jan J.

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0103-y.pdf

Reference49 articles.

1. Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122:491–8.

2. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–85.

3. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–75.

4. Szabolcs P, Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy. 2007;9:111–22.

5. Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood. 2010;115:1843–9.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamics of recent thymic emigrants in pediatric recipients of allogeneic hematopoetic stem cell transplantation;Bone Marrow Transplantation;2022-02-09

2. Cord blood transplantation for acute leukemia;Expert Opinion on Biological Therapy;2020-06-22

3. Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources;Expert Review of Clinical Immunology;2019-05-09

4. Medical Course and Complications After Hematopoietic Cell Transplantation;Psychosocial Care of End-Stage Organ Disease and Transplant Patients;2018-11-23

5. Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis;Blood;2018-06-14